Inspire Investing LLC Has $401,000 Stake in RadNet, Inc. (NASDAQ:RDNT)

Inspire Investing LLC decreased its holdings in RadNet, Inc. (NASDAQ:RDNT) by 3.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,744 shares of the medical research company’s stock after selling 189 shares during the quarter. Inspire Investing LLC’s holdings in RadNet were worth $401,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of RDNT. USA Financial Formulas bought a new position in shares of RadNet in the fourth quarter valued at about $30,000. Covestor Ltd increased its position in RadNet by 10,875.0% in the 3rd quarter. Covestor Ltd now owns 439 shares of the medical research company’s stock valued at $30,000 after acquiring an additional 435 shares in the last quarter. Highline Wealth Partners LLC bought a new position in shares of RadNet in the third quarter worth about $68,000. Peterson Financial Group Inc. acquired a new position in shares of RadNet during the third quarter worth approximately $90,000. Finally, GAMMA Investing LLC grew its stake in shares of RadNet by 57.3% during the third quarter. GAMMA Investing LLC now owns 1,361 shares of the medical research company’s stock valued at $94,000 after purchasing an additional 496 shares during the last quarter. Institutional investors and hedge funds own 77.90% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Jefferies Financial Group dropped their price objective on shares of RadNet from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, January 15th. Truist Financial restated a “buy” rating and set a $88.00 target price (down previously from $94.00) on shares of RadNet in a research report on Wednesday, January 22nd. Barclays decreased their price target on RadNet from $85.00 to $74.00 and set an “overweight” rating on the stock in a report on Wednesday, January 22nd. Finally, Sidoti raised RadNet to a “strong-buy” rating in a report on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, RadNet has a consensus rating of “Moderate Buy” and an average price target of $75.50.

Insider Buying and Selling at RadNet

In related news, EVP David Jeffrey Katz sold 12,300 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $81.65, for a total value of $1,004,295.00. Following the sale, the executive vice president now directly owns 62,909 shares in the company, valued at $5,136,519.85. This trade represents a 16.35 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Ranjan Jayanathan sold 38,557 shares of RadNet stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $80.00, for a total transaction of $3,084,560.00. Following the transaction, the insider now directly owns 192,724 shares in the company, valued at $15,417,920. The trade was a 16.67 % decrease in their position. The disclosure for this sale can be found here. Insiders own 5.12% of the company’s stock.

RadNet Stock Down 1.3 %

NASDAQ:RDNT opened at $64.08 on Monday. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.89. RadNet, Inc. has a 12-month low of $35.16 and a 12-month high of $93.65. The stock’s fifty day simple moving average is $73.75 and its 200-day simple moving average is $68.78. The firm has a market capitalization of $4.74 billion, a P/E ratio of -915.30 and a beta of 1.79.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.